ScholarIQanswers from OpenAlex

Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine

PaperCitations, authors & open-access status

Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine have?

ScholarIQcitation count

Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine has 758 citations in the OpenAlex counts ScholarIQ stores.

When was Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine published?

ScholarIQyear

Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine has 1996 year in the ScholarIQ index.

What is the open-access status of Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine?

ScholarIQoa status

Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine has bronze oa status in the ScholarIQ index.

What is the DOI of Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine?

ScholarIQdoi

The DOI for Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine is on the source record.

What is the PMID of Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine?

ScholarIQpmid

The PMID for Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine is on the source record.

What is the OpenAlex record for Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine?

ScholarIQopenalex

The OpenAlex for Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial